The Clorox Company (NYSE:CLX) Given Average Rating of “Reduce” by Brokerages

The Clorox Company (NYSE:CLX) has been given a consensus recommendation of “Reduce” by the seventeen brokerages that are covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $103.40.

A number of analysts recently commented on CLX shares. The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 price objective on shares of Clorox in a research report on Friday, May 1st. Royal Bank Of Canada dropped their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. Jefferies Financial Group dropped their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Evercore reiterated an “underperform” rating and set a $110.00 price objective on shares of Clorox in a research report on Friday, May 1st. Finally, Barclays dropped their price objective on Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research report on Friday, May 1st.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction dated Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.63% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp increased its stake in shares of Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after acquiring an additional 282,794 shares during the last quarter. Invesco Ltd. increased its stake in shares of Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after acquiring an additional 884,751 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Clorox by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after acquiring an additional 10,060 shares during the last quarter. Van ECK Associates Corp increased its stake in shares of Clorox by 15.7% during the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after acquiring an additional 426,433 shares during the last quarter. Finally, Two Sigma Investments LP increased its stake in shares of Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after acquiring an additional 439,797 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.9%

Clorox stock opened at $95.97 on Thursday. The stock has a market cap of $11.60 billion, a PE ratio of 15.58, a P/E/G ratio of 0.50 and a beta of 0.56. The stock has a 50-day moving average price of $96.33 and a 200 day moving average price of $105.12. Clorox has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter last year, the business posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts predict that Clorox will post 5.61 earnings per share for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.